Home
/
Forte Biosciences, Inc.
/
Financials
/
Quarterly
Forte Biosciences, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Forte Biosciences, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2019
Sep 30, 2019
$9.0K
Nov 12, 2019
Q2
2019
Jun 30, 2019
$9.0K
Aug 8, 2019
Q1
2020
Mar 31, 2019
$9.0K
Apr 23, 2020
Q3
2019
Sep 30, 2018
$18.01M
Nov 12, 2019
Q2
2019
Jun 30, 2018
$9.0K
Aug 8, 2019
Q1
2019
Mar 31, 2018
$9.0K
May 7, 2019
Q3
2018
Sep 30, 2017
$10.0K
Nov 8, 2018
Q2
2018
Jun 30, 2017
$10.0K
Aug 9, 2018
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($17.68M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($11.25M)
Aug 14, 2025
Q3
2025
Jun 30, 2025
($11.25M)
Nov 14, 2025
Q3
2025
Mar 31, 2025
($15.66M)
Nov 14, 2025
Q2
2025
Mar 31, 2025
($15.66M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($15.66M)
May 15, 2025
Q3
2025
Sep 30, 2024
($8.39M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($12.51M)
Aug 14, 2025
Q3
2025
Jun 30, 2024
($12.51M)
Nov 14, 2025
Q2
2025
Mar 31, 2024
($7.42M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($7.42M)
May 15, 2025
Q3
2025
Mar 31, 2024
($7.42M)
Nov 14, 2025
Q3
2024
Sep 30, 2023
($9.96M)
Nov 14, 2024
Q3
2024
Jun 30, 2023
($8.90M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($8.90M)
Aug 14, 2024
Q2
2024
Mar 31, 2023
($6.75M)
Aug 14, 2024
Q3
2024
Mar 31, 2023
($6.75M)
Nov 14, 2024
Q1
2024
Mar 31, 2023
($6.75M)
May 13, 2024
Q3
2023
Sep 30, 2022
($3.40M)
Nov 13, 2023
Q3
2023
Jun 30, 2022
($3.04M)
Nov 13, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($18.38M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($11.58M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($16.12M)
May 15, 2025
Q3
2025
Sep 30, 2024
($8.63M)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($12.82M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($7.80M)
May 15, 2025
Q3
2024
Sep 30, 2023
($10.22M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($9.03M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($6.86M)
May 13, 2024
Q3
2023
Sep 30, 2022
($3.42M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($3.02M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($2.51M)
May 15, 2023
Q3
2022
Sep 30, 2021
($7.70M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($5.75M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($4.74M)
May 16, 2022
Q3
2021
Sep 30, 2020
($5.01M)
Nov 8, 2021
Q2
2021
Jun 30, 2020
($34.75M)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($2.03M)
May 10, 2021
Q3
2020
Sep 30, 2019
($684.0K)
Nov 9, 2020
Q2
2020
Jun 30, 2019
($629.0K)
Aug 10, 2020